Literature DB >> 15800677

Gastrointestinal stromal tumors: a clinicopathologic and immunohistochemical study of 136 cases.

Zsolt Orosz1, Tamás Tornóczky, Zoltán Sápi.   

Abstract

The clinicopathologic features of 136 gastrointestinal stromal tumors were analyzed. The tumors occurred in 60 women and 76 men, ranging in age from 19 to 88 years (median 59 years, mean 59.2 years). Sixty-one cases arose from stomach, 38 from small intestine and 11 from colon or rectum. Abdominal cavity was indicated as tumor site in 10 cases, but the extra-gastrointestinal origin using strict criteria was not proved. Four locally recurrent cases and 12 metastatic samples were also included. The primary and recurrent tumors ranged in size from 0.5 to 30 cm (mean 8.3 cm). The large number of high-grade cases (85 of 112 classifiable) is alarming and emphasize the importance of oncology care. Histologically, ninety-two cases were classified as spindle cell while 11 as epithelioid GIST. Mixed cellularity was seen in 33 cases. Skeinoid fibers were present in 14 and coagulation necrosis in 40 primary cases. Ulceration observed by microscopic examination was common (36 of 110 cases, 32.7%), explaining the clinically frequently observed gastrointestinal bleeding. Unusual histological features such as stromal hyalinization and nuclear palisading were present in 30 and 27 cases, respectively. Immunohistochemical CD117 (c-kit) positivity was documented in 133 cases. Three cases with CD117 negative results were included, because their morphology was most consistent with GIST and immunohistochemical reactions excluded the possibility of other neoplasms. CD34 positivity was seen in 70%, alpha-smooth muscle actin positivity in 39.6% of examined cases. Only one case showed desmin reactivity and seven had S100 positive tumor cells. For h-caldesmon 39 cases proved to be positive (60.9% of the tested cases).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15800677     DOI: 10.1007/BF03032400

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  35 in total

1.  Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Authors:  H Joensuu; P J Roberts; M Sarlomo-Rikala; L C Andersson; P Tervahartiala; D Tuveson; S Silberman; R Capdeville; S Dimitrijevic; B Druker; G D Demetri
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

2.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Gastrointestinal autonomic nerve tumor: immunohistochemical and molecular identity with gastrointestinal stromal tumor.

Authors:  J R Lee; V Joshi; J W Griffin ; J Lasota; M Miettinen
Journal:  Am J Surg Pathol       Date:  2001-08       Impact factor: 6.394

Review 4.  Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib.

Authors:  Chandu M V de Silva; Robin Reid
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

Review 5.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

6.  Schwannomas in the colon and rectum: a clinicopathologic and immunohistochemical study of 20 cases.

Authors:  M Miettinen; K M Shekitka; L H Sobin
Journal:  Am J Surg Pathol       Date:  2001-07       Impact factor: 6.394

7.  Gastric stromal tumors. Reappraisal of histogenesis.

Authors:  M T Mazur; H B Clark
Journal:  Am J Surg Pathol       Date:  1983-09       Impact factor: 6.394

Review 8.  Biology of gastrointestinal stromal tumors.

Authors:  Christopher L Corless; Jonathan A Fletcher; Michael C Heinrich
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

9.  Gastrointestinal stromal tumors--value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas.

Authors:  M Miettinen; M Virolainen
Journal:  Am J Surg Pathol       Date:  1995-02       Impact factor: 6.394

10.  Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade.

Authors:  Tadashi Hasegawa; Yoshihiro Matsuno; Tadakazu Shimoda; Setsuo Hirohashi
Journal:  Hum Pathol       Date:  2002-06       Impact factor: 3.466

View more
  21 in total

1.  Spontaneous leiomyomas of the gastroesophageal junction in a chimpanzee (Pan troglodytes).

Authors:  Sanjeev Gumber; Melissa I Stovall; Eileen Breding; Maria M Crane
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

2.  Gastrointestinal stromal tumors-diagnosis and management: a brief review.

Authors:  Stephen T Gerrish; James W Smith
Journal:  Ochsner J       Date:  2008

3.  Gastrointestinal stromal tumors: a clinicopathological and immunohistochemical study of 121 cases.

Authors:  Mukul Vij; Vinita Agrawal; Ashok Kumar; Rakesh Pandey
Journal:  Indian J Gastroenterol       Date:  2011-01-11

Review 4.  Giant ileal gastrointestinal stromal tumour presenting as an intestinal subocclusion and subsequent haemoperitoneum: a case report and a review of the literature.

Authors:  Domenico Iusco; Marcello Jannaci; Antonio Grassi; Serena Bonomi; Ismail Ismail; Giuseppe Navarra; Salvatore Virzì
Journal:  Updates Surg       Date:  2010-11-30

5.  Spontaneous rupture of a gastric stromal tumor causing hemoperitoneum.

Authors:  Gun Wha Lee; Young Seok Kim; Sang Gyune Kim; Bong Min Ko; Moon Sung Lee; Kyu Seok Cho; Seong Jin Park; Hee Kyung Kim
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

6.  Colorectal gastrointestinal stromal tumors: a brief review.

Authors:  Rishindra M Reddy; James W Fleshman
Journal:  Clin Colon Rectal Surg       Date:  2006-05

7.  p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome.

Authors:  Michael Schmieder; Sebastian Wolf; Bettina Danner; Susanne Stoehr; Markus S Juchems; Peter Wuerl; Doris Henne-Bruns; Uwe Knippschild; Cornelia Hasel; Klaus Kramer
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

8.  The outcome of gastrointestinal stromal tumors (GISTs) after a surgical resection in our institute.

Authors:  Kazunori Tsukuda; Ryuji Hirai; Takayoshi Miyake; Shoji Takagi; Eiji Ikeda; Tadayoshi Kunitomo; Hisashi Tsuji
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

9.  Gastrointestinal stromal tumors-a morphological and immunohistochemical study.

Authors:  Sajid Mushtaq; Nadira Mamoon; Usman Hassan; Muhammad Iqbal; Muhammad Tahir Khadim; Tariq Sarfraz
Journal:  J Gastrointest Cancer       Date:  2009-11-20

Review 10.  Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population.

Authors:  Lori Rink; Andrew K Godwin
Journal:  Curr Oncol Rep       Date:  2009-07       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.